Baxano Surgical, Inc., formerly Baxano Inc. is a medical device company. The Company is focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. The Company markets the AxiaLIF pre-sacral access and interbody fusion system for single and two level lower lumbar fusion, the VEO lateral access and interbody fusion system, the iO-Flex set of flexible instruments used by surgeons during spinal decompression procedures, and the iO-Tome instrument for rapid and precise removal of bone, specifically the facet joints, a technique which is commonly performed in spinal fusion procedures. The Company's other products include: Vectre facet screw system, Bi-Ostetic bone void filler, bowel retractors, discectomy tools, and a bone graft harvesting system that can be used to extract bone graft from the patient's hip for use in fusion procedures.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:BAXS
- CUSIP: N/A
- Web: N/A
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.06
- P/E Growth: N/A
Frequently Asked Questions for Baxano Surgical (NASDAQ:BAXS)
What is Baxano Surgical's stock symbol?
Baxano Surgical trades on the NASDAQ under the ticker symbol "BAXS."
How were Baxano Surgical's earnings last quarter?
Baxano Surgical Inc (NASDAQ:BAXS) issued its earnings results on Tuesday, August, 5th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.14) by $0.04. View Baxano Surgical's Earnings History.
Who are some of Baxano Surgical's key competitors?
Some companies that are related to Baxano Surgical include Orange Belgium (MBSRF), Abengoa SA (ABGB), Apple (AAPL), Alphabet (GOOGL), Alphabet (GOOG), Microsoft (MSFT), Amazon.com (AMZN), Premier Foods Spon (PRRFY), Facebook (FB), Berkshire Hathaway (BRK-A), Nestle SA (NSRGY), Roche Holding (RHHBY), RDS-A (RDS-A), Comcast (CMCSA), Intel (INTC), Cisco Systems (CSCO), LVMH Moet Hennessy Louis Vuitton SE (LVMUY) and Inditex (IDEXY).
How do I buy Baxano Surgical stock?
Shares of Baxano Surgical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Baxano Surgical stock cost?
One share of Baxano Surgical stock can currently be purchased for approximately $0.02.
Consensus Ratings for Baxano Surgical (NASDAQ:BAXS) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Baxano Surgical (NASDAQ:BAXS)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Baxano Surgical (NASDAQ:BAXS)Earnings History by Quarter for Baxano Surgical (NASDAQ:BAXS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/8/2013||Q2 2013||($0.14)||($0.21)||$6.90 million||$3.90 million||View||N/A|
Earnings Estimates for Baxano Surgical (NASDAQ:BAXS)
Current Year EPS Consensus Estimate: $-0.5700 EPS
Next Year EPS Consensus Estimate: $-0.4000 EPS
Dividend History for Baxano Surgical (NASDAQ:BAXS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Baxano Surgical (NASDAQ:BAXS)Insider Trades by Quarter for Baxano Surgical (NASDAQ:BAXS)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/15/2014||Kenneth Michael Reali||CEO||Buy||10,000||$0.38||$3,800.00|| |
|5/12/2014||Kenneth Michael Reali||CEO||Buy||7,050||$0.71||$5,005.50|| |
|12/5/2013||Kenneth Michael Reali||CEO||Buy||10,500||$1.11||$11,655.00|| |
|5/31/2013||Roderick A Young||Director||Buy||1,340,034||$2.28||$3,055,277.52|| |
Headline Trends for Baxano Surgical (NASDAQ:BAXS)
Latest Headlines for Baxano Surgical (NASDAQ:BAXS)
Baxano Surgical (BAXS) Chart for Thursday, May, 25, 2017